SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3NG'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FMO_E_ADNE351_1
(CAMP-DEPENDENT
PROTEIN KINASE)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
GLY A 168
VAL A 175
ALA A 189
VAL A 225
ASN A 293
LEU A 295
ASP A 325
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
None
None
None
3NG  A 501 (-4.3A)
 0.78A 1fmoE-6fyvA:
25.5		 1fmoE-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IEP_A_STIA201_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.26A 1iepA-6fylA:
21.6		 1iepA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.56A 1opjB-6fylA:
21.4		 1opjB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OPJ_B_STIB4_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
 0.60A 1opjB-6fyvA:
21.3		 1opjB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 0.99A 1t46A-6fylA:
22.4		 1t46A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
VAL A 227
GLY A 247
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 0.83A 1t46A-6fylA:
22.4		 1t46A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		9 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
LEU A 210
GLY A 245
LEU A 295
ASP A 325
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
3NG  A 501 (-4.3A)
 1.07A 1t46A-6fyvA:
22.2		 1t46A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T46_A_STIA3_1
(HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		9 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
LEU A 210
VAL A 225
GLY A 245
ASP A 325
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
3NG  A 501 (-4.3A)
 0.90A 1t46A-6fyvA:
22.2		 1t46A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.52A 1uwhA-6fylA:
22.6		 1uwhA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 ALA A 189
GLU A 206
LEU A 210
LEU A 279
HIS A 286
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
None
 0.68A 1uwhA-6fyvA:
22.5		 1uwhA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_B_BAXB1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 0.59A 1uwhB-6fylA:
22.4		 1uwhB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_B_BAXB1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 12 ALA A 189
LYS A 191
GLU A 206
LEU A 210
LEU A 279
HIS A 286
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 0.67A 1uwhB-6fyvA:
22.4		 1uwhB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
GLU A 208
LEU A 281
HIS A 288
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
 0.56A 1uwjA-6fylA:
22.2		 1uwjA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EUF_B_LQQB401_1
(CELL DIVISION
PROTEIN KINASE 6)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
LYS A 193
VAL A 227
PHE A 243
ASN A 295
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
None
3NG  A 501 (-3.5A)
None
None
3NG  A 501 (-4.5A)
 0.86A 2eufB-6fylA:
30.4		 2eufB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EUF_B_LQQB401_1
(CELL DIVISION
PROTEIN KINASE 6)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 VAL A 175
LYS A 191
VAL A 225
PHE A 241
ASN A 293
LEU A 295
ASP A 325
 3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
None
3NG  A 501 (-3.5A)
None
None
3NG  A 501 (-4.3A)
 0.68A 2eufB-6fyvA:
31.3		 2eufB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.54A 2hyyB-6fylA:
22.1		 2hyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 (-3.9A)
None
None
None
 0.69A 2hyyB-6fylA:
22.1		 2hyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
 0.64A 2hyyB-6fyvA:
22.0		 2hyyB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
VAL A 209
VAL A 225
ILE A 239
 3NG  A 501 (-3.9A)
None
None
None
 0.72A 2hyyB-6fyvA:
22.0		 2hyyB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_C_STIC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.65A 2hyyC-6fylA:
22.2		 2hyyC-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_C_STIC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
 0.71A 2hyyC-6fyvA:
22.1		 2hyyC-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_D_STID600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
ILE A 215
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.23A 2hyyD-6fylA:
16.2		 2hyyD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_C_B49C1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 VAL A 177
ALA A 191
PHE A 243
LEU A 245
ASP A 252
LEU A 297
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
 0.65A 2y7jC-6fylA:
28.1		 2y7jC-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_C_B49C1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 10 VAL A 175
ALA A 189
PHE A 241
LEU A 243
ASP A 250
LEU A 295
 3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
 0.64A 2y7jC-6fyvA:
28.1		 2y7jC-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_D_B49D1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 VAL A 177
ALA A 191
PHE A 243
LEU A 245
ASP A 252
LEU A 297
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
 0.62A 2y7jD-6fylA:
28.2		 2y7jD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_D_B49D1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 10 VAL A 175
ALA A 189
PHE A 241
LEU A 243
ASP A 250
LEU A 295
 3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
 0.63A 2y7jD-6fyvA:
28.2		 2y7jD-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 LEU A 169
VAL A 177
VAL A 227
ILE A 241
VAL A 325
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
None
None
None
3NG  A 501 (-4.5A)
 0.80A 3cs9A-6fylA:
21.7		 3cs9A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 10 LEU A 167
VAL A 175
VAL A 225
ILE A 239
VAL A 323
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
None
None
None
 0.61A 3cs9A-6fyvA:
21.6		 3cs9A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_A_NILA600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 10 LEU A 167
VAL A 225
ILE A 239
VAL A 323
ASP A 325
 3NG  A 501 (-3.9A)
None
None
None
3NG  A 501 (-4.3A)
 0.90A 3cs9A-6fyvA:
21.6		 3cs9A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 LEU A 169
VAL A 177
LYS A 193
ILE A 241
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
None
None
 0.89A 3cs9B-6fylA:
17.1		 3cs9B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 9 LEU A 169
VAL A 177
VAL A 227
ILE A 241
LEU A 297
VAL A 325
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
None
None
None
None
 0.77A 3cs9B-6fylA:
17.1		 3cs9B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 9 LEU A 167
VAL A 175
LYS A 191
VAL A 225
ILE A 239
LEU A 244
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
None
None
3NG  A 501 (-4.1A)
 1.30A 3cs9B-6fyvA:
21.8		 3cs9B-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 9 LEU A 167
VAL A 175
LYS A 191
VAL A 225
ILE A 239
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
None
None
None
 0.88A 3cs9B-6fyvA:
21.8		 3cs9B-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_B_NILB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 9 LEU A 167
VAL A 175
VAL A 225
ILE A 239
LEU A 295
VAL A 323
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
None
None
None
None
 0.73A 3cs9B-6fyvA:
21.8		 3cs9B-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_C_NILC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 LEU A 169
VAL A 177
VAL A 227
ILE A 241
VAL A 325
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
None
None
None
 0.52A 3cs9C-6fylA:
21.5		 3cs9C-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_C_NILC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 9 LEU A 167
VAL A 175
VAL A 225
ILE A 239
VAL A 323
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
None
None
None
 0.59A 3cs9C-6fyvA:
21.4		 3cs9C-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CS9_D_NILD600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
VAL A 175
LYS A 191
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
None
 0.87A 3cs9D-6fyvA:
20.5		 3cs9D-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GP0_A_NILA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 11)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 VAL A 177
ALA A 191
GLU A 208
LEU A 212
HIS A 288
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.08A 3gp0A-6fylA:
25.8		 3gp0A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GVU_A_STIA1001_1
(TYROSINE-PROTEIN
KINASE ABL2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
VAL A 227
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 0.98A 3gvuA-6fylA:
22.0		 3gvuA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEC_A_STIA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
LEU A 245
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 ( 4.7A)
 0.55A 3hecA-6fylA:
25.2		 3hecA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEC_A_STIA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 ALA A 189
LYS A 191
GLU A 206
LEU A 210
LEU A 243
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
3NG  A 501 ( 4.7A)
 0.60A 3hecA-6fyvA:
25.2		 3hecA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
 0.81A 3hegA-6fylA:
24.7		 3hegA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
GLU A 208
ILE A 215
VAL A 227
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.67A 3ik3A-6fylA:
16.2		 3ik3A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.57A 3ik3A-6fylA:
16.2		 3ik3A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 7 LEU A 167
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
 0.63A 3ik3A-6fyvA:
21.7		 3ik3A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
GLU A 208
ILE A 215
VAL A 227
HIS A 288
LEU A 297
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
None
 0.79A 3ik3B-6fylA:
21.5		 3ik3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.57A 3ik3B-6fylA:
21.6		 3ik3B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 7 LEU A 167
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
 0.62A 3ik3B-6fyvA:
21.5		 3ik3B-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.54A 3k5vA-6fylA:
21.4		 3k5vA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 (-3.9A)
None
None
None
 0.67A 3k5vA-6fylA:
21.4		 3k5vA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
 0.60A 3k5vA-6fyvA:
15.9		 3k5vA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
VAL A 209
VAL A 225
ILE A 239
 3NG  A 501 (-3.9A)
None
None
None
 0.68A 3k5vA-6fyvA:
15.9		 3k5vA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
 0.59A 3k5vB-6fylA:
21.2		 3k5vB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 LEU A 169
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 (-3.9A)
None
None
None
 0.78A 3k5vB-6fylA:
21.2		 3k5vB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
 0.67A 3k5vB-6fyvA:
21.2		 3k5vB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 LEU A 167
VAL A 209
VAL A 225
ILE A 239
 3NG  A 501 (-3.9A)
None
None
None
 0.79A 3k5vB-6fyvA:
21.2		 3k5vB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MS9_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.21A 3ms9A-6fylA:
16.2		 3ms9A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_A_STIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 1.20A 3mssA-6fylA:
2.3		 3mssA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_C_STIC1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
 1.05A 3mssC-6fylA:
21.6		 3mssC-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 VAL A 177
LYS A 193
VAL A 211
ILE A 241
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
None
None
 0.55A 3mssD-6fylA:
21.7		 3mssD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 6 VAL A 177
VAL A 211
VAL A 227
ILE A 241
 3NG  A 501 ( 4.4A)
None
None
None
 0.75A 3mssD-6fylA:
21.7		 3mssD-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 VAL A 175
LYS A 191
VAL A 209
ILE A 239
 3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
None
None
 0.53A 3mssD-6fyvA:
21.5		 3mssD-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_D_STID1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 6 VAL A 175
VAL A 209
VAL A 225
ILE A 239
 3NG  A 501 ( 4.3A)
None
None
None
 0.67A 3mssD-6fyvA:
21.5		 3mssD-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OEZ_B_STIB601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 VAL A 175
ALA A 189
LYS A 191
GLU A 206
VAL A 209
ILE A 239
LEU A 295
 3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 0.78A 3oezB-6fyvA:
22.1		 3oezB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B1000_1
(P38A)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 GLY A 170
VAL A 177
ALA A 191
LYS A 193
LEU A 212
GLY A 247
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
 0.72A 3ohtB-6fylA:
5.0		 3ohtB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
GLU A 208
ILE A 215
VAL A 227
GLY A 247
HIS A 288
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
None
3NG  A 501 (-4.5A)
 1.22A 3oxzA-6fylA:
21.6		 3oxzA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 LEU A 169
LYS A 193
VAL A 211
ILE A 241
LEU A 246
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
3NG  A 501 (-4.2A)
 1.04A 3oxzA-6fylA:
21.7		 3oxzA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 9 LEU A 169
LYS A 193
VAL A 211
ILE A 241
LEU A 297
VAL A 325
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.0A)
None
None
None
None
 0.96A 3oxzA-6fylA:
21.7		 3oxzA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 9 LEU A 167
LYS A 191
VAL A 209
ILE A 239
LEU A 244
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
3NG  A 501 (-4.1A)
 1.08A 3oxzA-6fyvA:
21.5		 3oxzA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 9 LEU A 167
LYS A 191
VAL A 209
ILE A 239
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 (-2.7A)
None
None
None
 0.81A 3oxzA-6fyvA:
21.5		 3oxzA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXZ_A_0LIA1_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 9 LEU A 167
VAL A 209
ILE A 239
LEU A 295
VAL A 323
 3NG  A 501 (-3.9A)
None
None
None
None
 0.83A 3oxzA-6fyvA:
21.5		 3oxzA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_B_STIB4_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
ILE A 215
VAL A 227
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.83A 3pyyB-6fylA:
21.5		 3pyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_B_STIB4_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
VAL A 227
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 0.94A 3pyyB-6fylA:
21.5		 3pyyB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_B_STIB4_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 12 LEU A 167
VAL A 175
ALA A 189
GLU A 206
VAL A 225
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
 0.76A 3pyyB-6fyvA:
21.4		 3pyyB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RGF_A_BAXA465_1
(CYCLIN-DEPENDENT
KINASE 8)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
LEU A 212
PHE A 243
LEU A 281
HIS A 288
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 (-3.5A)
None
None
 0.62A 3rgfA-6fylA:
6.9		 3rgfA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RGF_A_BAXA465_1
(CYCLIN-DEPENDENT
KINASE 8)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 VAL A 175
ALA A 189
GLU A 206
LEU A 210
PHE A 241
LEU A 279
HIS A 286
 3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
3NG  A 501 (-3.5A)
None
None
 0.58A 3rgfA-6fyvA:
25.2		 3rgfA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UE4_A_DB8A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
ILE A 241
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 1.23A 3ue4A-6fylA:
24.4		 3ue4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UE4_A_DB8A601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 LEU A 167
ALA A 189
LYS A 191
GLU A 206
ILE A 239
GLY A 245
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 1.29A 3ue4A-6fyvA:
24.3		 3ue4A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WAR_A_NIOA401_1
(CASEIN KINASE II
SUBUNIT ALPHA)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 8 VAL A 175
LYS A 191
PHE A 241
ASP A 325
 3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 (-3.5A)
3NG  A 501 (-4.3A)
 0.61A 3warA-6fyvA:
29.1		 3warA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
LEU A 212
GLY A 247
LEU A 281
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.72A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
 0.67A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
LEU A 212
GLY A 247
LEU A 281
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
 0.71A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
 0.60A 3wzeA-6fylA:
22.2		 3wzeA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
LEU A 210
HIS A 286
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
 0.57A 3wzeA-6fyvA:
21.9		 3wzeA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_A_0LIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 LEU A 167
ALA A 189
LYS A 191
GLU A 206
LEU A 279
HIS A 286
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 0.79A 3zosA-6fyvA:
20.9		 3zosA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AG8_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
VAL A 227
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 1.07A 4ag8A-6fylA:
22.1		 4ag8A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AG8_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
VAL A 225
GLY A 245
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 1.15A 4ag8A-6fyvA:
21.8		 4ag8A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AGC_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
LEU A 212
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
 1.04A 4agcA-6fylA:
21.7		 4agcA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AGC_A_AXIA2000_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
LEU A 210
GLY A 245
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 1.15A 4agcA-6fyvA:
21.4		 4agcA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 212
GLY A 247
LEU A 281
HIS A 288
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
None
 0.87A 4asdA-6fylA:
22.0		 4asdA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
LEU A 210
GLY A 245
HIS A 286
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 0.91A 4asdA-6fyvA:
21.7		 4asdA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
VAL A 175
LYS A 191
GLU A 206
LEU A 210
GLY A 245
LEU A 279
HIS A 286
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
None
 1.05A 4asdA-6fyvA:
21.7		 4asdA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
LYS A 193
GLU A 208
ILE A 241
HIS A 288
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 0.95A 4c8bA-6fylA:
22.1		 4c8bA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
ILE A 241
HIS A 288
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.02A 4c8bA-6fylA:
22.1		 4c8bA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 ALA A 189
GLU A 206
LEU A 210
ILE A 239
HIS A 286
LEU A 295
ASP A 325
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
None
None
None
3NG  A 501 (-4.3A)
 1.06A 4c8bA-6fyvA:
22.4		 4c8bA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 ALA A 189
LYS A 191
GLU A 206
LEU A 210
ILE A 239
HIS A 286
LEU A 295
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
None
 0.75A 4c8bA-6fyvA:
22.4		 4c8bA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CKJ_A_ADNA2014_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 10 LEU A 167
GLY A 168
GLY A 170
VAL A 175
ALA A 189
SER A 247
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
None
 0.41A 4ckjA-6fyvA:
24.8		 4ckjA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I41_A_MIXA500_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
ASP A 290
LYS A 292
ASN A 295
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
None
None
None
None
3NG  A 501 (-4.5A)
 0.64A 4i41A-6fylA:
25.4		 4i41A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IAA_A_RTZA401_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 11 VAL A 175
ALA A 189
LYS A 191
GLU A 292
LEU A 295
ASP A 325
 3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
None
3NG  A 501 (-4.3A)
 1.00A 4iaaA-6fyvA:
25.1		 4iaaA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O0S_A_ADNA500_1
(AURORA KINASE A)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 11 LEU A 167
GLY A 168
VAL A 175
ALA A 189
LYS A 191
ASN A 293
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
None
 0.72A 4o0sA-6fyvA:
26.5		 4o0sA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O0W_A_ADNA501_1
(AURORA KINASE A)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 6 LEU A 169
GLY A 170
VAL A 177
ALA A 191
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
None
 0.39A 4o0wA-6fylA:
25.4		 4o0wA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O0W_A_ADNA501_1
(AURORA KINASE A)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 6 LEU A 167
GLY A 168
VAL A 175
ALA A 189
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
None
 0.51A 4o0wA-6fyvA:
25.6		 4o0wA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OTI_A_MI1A1001_1
(SERINE/THREONINE-PRO
TEIN KINASE N1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
GLY A 170
GLY A 172
GLY A 175
VAL A 177
ALA A 191
LYS A 193
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.5A)
None
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
 0.52A 4otiA-6fylA:
21.2		 4otiA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OTI_A_MI1A1001_1
(SERINE/THREONINE-PRO
TEIN KINASE N1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
GLY A 170
GLY A 175
VAL A 177
ALA A 191
LYS A 193
VAL A 227
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
None
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
 0.62A 4otiA-6fylA:
21.2		 4otiA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OTI_A_MI1A1001_1
(SERINE/THREONINE-PRO
TEIN KINASE N1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
GLY A 168
GLY A 170
GLY A 173
VAL A 175
ALA A 189
LYS A 191
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
 0.63A 4otiA-6fyvA:
21.4		 4otiA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMN_A_DB8A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
LYS A 193
GLU A 208
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
3NG  A 501 (-4.5A)
 0.75A 4qmnA-6fylA:
26.6		 4qmnA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMS_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 11 ALA A 189
LYS A 191
GLU A 206
ILE A 239
LEU A 295
ASP A 325
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
3NG  A 501 (-4.3A)
 0.71A 4qmsA-6fyvA:
26.7		 4qmsA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R7I_A_STIA1001_1
(MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 (-4.5A)
 0.74A 4r7iA-6fylA:
22.0		 4r7iA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TYJ_A_0LIA801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 4)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
GLU A 208
ILE A 215
HIS A 288
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.19A 4tyjA-6fylA:
22.3		 4tyjA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U0I_A_0LIA1001_2
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
KIT,MAST/STEM CELL
GROWTH FACTOR
RECEPTOR KIT)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 ALA A 191
LYS A 193
LEU A 212
GLY A 247
HIS A 288
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
None
None
3NG  A 501 (-4.5A)
 1.15A 4u0iA-6fylA:
22.4		 4u0iA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U0I_A_0LIA1001_2
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
KIT,MAST/STEM CELL
GROWTH FACTOR
RECEPTOR KIT)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 ALA A 189
LYS A 191
LEU A 210
GLY A 245
HIS A 286
LEU A 295
ASP A 325
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
None
None
None
3NG  A 501 (-4.3A)
 1.17A 4u0iA-6fyvA:
22.3		 4u0iA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WKQ_A_IREA1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
LEU A 245
ASP A 252
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
 0.53A 4wkqA-6fylA:
24.0		 4wkqA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WKQ_A_IREA1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
 1.10A 4wkqA-6fylA:
24.0		 4wkqA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WKQ_A_IREA1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 12 LEU A 167
ALA A 189
LYS A 191
GLU A 206
LEU A 243
ASP A 250
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
3NG  A 501 ( 4.7A)
None
 0.52A 4wkqA-6fyvA:
23.7		 4wkqA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WKQ_A_IREA1101_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		7 / 12 LEU A 167
ALA A 189
LYS A 191
GLU A 206
LEU A 243
GLY A 245
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
3NG  A 501 ( 4.7A)
None
None
 1.18A 4wkqA-6fyvA:
23.7		 4wkqA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 ALA A 191
LYS A 193
LEU A 212
ASP A 327
PHE A 328
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
3NG  A 501 (-4.5A)
None
 0.93A 4xv2B-6fylA:
22.2		 4xv2B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 ALA A 189
LYS A 191
LEU A 210
ASP A 325
PHE A 326
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
3NG  A 501 (-4.3A)
None
 0.92A 4xv2B-6fyvA:
22.3		 4xv2B-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
LYS A 193
LEU A 212
PHE A 328
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
 0.82A 5cswA-6fylA:
21.4		 5cswA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 VAL A 175
ALA A 189
LYS A 191
LEU A 210
PHE A 326
 3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
None
 0.74A 5cswA-6fyvA:
21.4		 5cswA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 VAL A 177
ALA A 191
LYS A 193
LEU A 212
PHE A 328
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
None
None
 0.84A 5cswB-6fylA:
21.4		 5cswB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 VAL A 175
ALA A 189
LYS A 191
LEU A 210
PHE A 326
 3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
None
None
 0.77A 5cswB-6fyvA:
21.4		 5cswB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI2_A_BAXA801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 ALA A 191
LYS A 193
GLU A 208
LEU A 212
LEU A 281
HIS A 288
 3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 0.63A 5hi2A-6fylA:
22.6		 5hi2A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI2_A_BAXA801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 12 ALA A 189
LYS A 191
GLU A 206
LEU A 210
LEU A 279
HIS A 286
 3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
None
 0.77A 5hi2A-6fyvA:
22.5		 5hi2A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_G_AZ1G2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 GLY A 170
GLY A 172
VAL A 177
LYS A 193
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
 0.46A 5izjA-6fylA:
25.1		 5izjA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_G_AZ1G2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 7 GLY A 168
GLY A 170
VAL A 175
LYS A 191
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
 0.34A 5izjA-6fyvA:
25.6		 5izjA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J5X_B_AZ1B2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAL-DAR-DAR-
DAR-DAR)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 GLY A 170
GLY A 172
VAL A 177
LYS A 193
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
 0.34A 5j5xA-6fylA:
25.1		 5j5xA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J5X_B_AZ1B2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAL-DAR-DAR-
DAR-DAR)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 7 GLY A 168
GLY A 170
VAL A 175
LYS A 191
ASP A 325
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 (-4.3A)
 0.68A 5j5xA-6fyvA:
25.6		 5j5xA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_H_ADNH401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 9 GLY A 170
VAL A 177
ALA A 191
LEU A 245
LEU A 297
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.7A)
None
 1.07A 5lw1H-6fylA:
17.4		 5lw1H-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 10 LEU A 169
VAL A 177
LYS A 193
GLU A 208
ILE A 241
GLY A 247
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
 0.67A 5mo4A-6fylA:
19.0		 5mo4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		6 / 10 LEU A 167
VAL A 175
LYS A 191
GLU A 206
ILE A 239
GLY A 245
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
None
 0.67A 5mo4A-6fyvA:
9.7		 5mo4A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OWR_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 8 ALA A 191
GLU A 208
LEU A 297
ASP A 327
 3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
3NG  A 501 (-4.5A)
 0.66A 5owrA-6fylA:
14.9		 5owrA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OWR_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 8 ALA A 189
GLU A 206
LEU A 295
ASP A 325
 3NG  A 501 (-3.5A)
3NG  A 501 ( 4.7A)
None
3NG  A 501 (-4.3A)
 0.62A 5owrA-6fyvA:
22.1		 5owrA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCV_A_1N1A404_1
(MEMBRANE-ASSOCIATED
TYROSINE- AND
THREONINE-SPECIFIC
CDC2-INHIBITORY
KINASE)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 LEU A 167
ALA A 189
LYS A 191
GLU A 206
GLY A 245
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
None
 0.47A 5vcvA-6fyvA:
27.2		 5vcvA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WWS_B_SAMB501_0
(PUTATIVE
METHYLTRANSFERASE
NSUN6)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		5 / 12 GLY A 172
ILE A 241
LYS A 193
ASP A 234
GLY A 237
 3NG  A 501 ( 4.5A)
None
3NG  A 501 (-3.0A)
None
None
 1.04A 5wwsB-6fylA:
undetectable		 5wwsB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WWS_B_SAMB501_0
(PUTATIVE
METHYLTRANSFERASE
NSUN6)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 GLY A 170
ILE A 239
LYS A 191
ASP A 232
GLY A 235
 3NG  A 501 ( 4.9A)
None
3NG  A 501 (-2.7A)
None
None
 1.12A 5wwsB-6fyvA:
undetectable		 5wwsB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XV7_A_EMHA705_1
(SERINE-ARGININE (SR)
PROTEIN KINASE 1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		6 / 12 LEU A 169
GLY A 170
VAL A 177
ALA A 191
PHE A 243
GLY A 247
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.5A)
None
 0.62A 5xv7A-6fylA:
37.1		 5xv7A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XV7_A_EMHA705_1
(SERINE-ARGININE (SR)
PROTEIN KINASE 1)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		5 / 12 LEU A 167
GLY A 168
VAL A 175
ALA A 189
PHE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-3.5A)
 0.34A 5xv7A-6fyvA:
36.2		 5xv7A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
 0.79A 5y7zA-6fylA:
25.3		 5y7zA-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
LEU A 243
GLY A 245
LEU A 295
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
3NG  A 501 ( 4.7A)
None
None
 0.93A 5y7zA-6fyvA:
25.2		 5y7zA-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_B_IREB401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		8 / 12 LEU A 169
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
3NG  A 501 (-4.5A)
 0.94A 5y7zB-6fylA:
16.7		 5y7zB-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7Z_B_IREB401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		8 / 12 LEU A 167
ALA A 189
LYS A 191
GLU A 206
LEU A 243
GLY A 245
LEU A 295
ASP A 325
 3NG  A 501 (-3.9A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
3NG  A 501 ( 4.7A)
None
None
3NG  A 501 (-4.3A)
 0.98A 5y7zB-6fyvA:
16.7		 5y7zB-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y80_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		9 / 12 LEU A 169
VAL A 177
ALA A 191
LYS A 193
GLU A 208
LEU A 245
GLY A 247
LEU A 297
ASP A 327
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
3NG  A 501 ( 4.7A)
None
None
3NG  A 501 (-4.5A)
 0.92A 5y80A-6fylA:
24.3		 5y80A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y80_A_IREA401_0
(CYCLIN-G-ASSOCIATED
KINASE)		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		9 / 12 LEU A 167
VAL A 175
ALA A 189
LYS A 191
GLU A 206
LEU A 243
GLY A 245
LEU A 295
ASP A 325
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-3.5A)
3NG  A 501 (-2.7A)
3NG  A 501 ( 4.7A)
3NG  A 501 ( 4.7A)
None
None
3NG  A 501 (-4.3A)
 0.98A 5y80A-6fyvA:
24.1		 5y80A-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9M_X_NIOX401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 8 LEU A 169
VAL A 177
LYS A 193
PHE A 243
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
3NG  A 501 (-3.5A)
 0.71A 5y9mX-6fylA:
27.7		 5y9mX-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9M_X_NIOX401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 8 LEU A 167
VAL A 175
LYS A 191
PHE A 241
 3NG  A 501 (-3.9A)
3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 (-3.5A)
 0.66A 5y9mX-6fyvA:
28.2		 5y9mX-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9M_X_NIOX401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 8 VAL A 175
LYS A 191
PHE A 241
ASP A 325
 3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 (-3.5A)
3NG  A 501 (-4.3A)
 0.46A 5y9mX-6fyvA:
28.2		 5y9mX-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YF9_B_NIOB401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		4 / 7 VAL A 177
LYS A 193
PHE A 243
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.0A)
3NG  A 501 (-3.5A)
3NG  A 501 (-4.5A)
 0.83A 5yf9B-6fylA:
27.6		 5yf9B-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YF9_B_NIOB401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 7 VAL A 175
LYS A 191
PHE A 241
ASP A 325
 3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 (-3.5A)
3NG  A 501 (-4.3A)
 0.66A 5yf9B-6fyvA:
27.9		 5yf9B-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YWM_X_NIOX403_0
(CASEIN KINASE II
SUBUNIT ALPHA')		 6fyv DUAL SPECIFICITY
PROTEIN KINASE CLK4
(Homo
sapiens) 		4 / 7 VAL A 175
LYS A 191
PHE A 241
ASP A 325
 3NG  A 501 ( 4.3A)
3NG  A 501 (-2.7A)
3NG  A 501 (-3.5A)
3NG  A 501 (-4.3A)
 0.53A 5ywmX-6fyvA:
27.8		 5ywmX-6fyvA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
ILE A 215
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.20A 6hd4A-6fylA:
7.3		 6hd4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
VAL A 227
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.03A 6hd4A-6fylA:
7.3		 6hd4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
LYS A 193
GLU A 208
ILE A 215
ILE A 241
LEU A 297
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 (-3.0A)
3NG  A 501 ( 4.9A)
None
None
None
 1.01A 6hd4A-6fylA:
7.3		 6hd4A-6fylA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HD4_B_STIB602_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6fyl DUAL SPECIFICITY
PROTEIN KINASE CLK2
(Homo
sapiens) 		7 / 12 VAL A 177
ALA A 191
GLU A 208
ILE A 215
ILE A 241
LEU A 297
ASP A 327
 3NG  A 501 ( 4.4A)
3NG  A 501 (-3.3A)
3NG  A 501 ( 4.9A)
None
None
None
3NG  A 501 (-4.5A)
 1.18A 6hd4B-6fylA:
21.2		 6hd4B-6fylA:
undetectable